AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,723,887 | -46.1% | 69,652 | -38.3% | 0.00% | -40.0% |
| Q2 2023 | $3,195,969 | +158.2% | 112,852 | +102.0% | 0.01% | +150.0% |
| Q2 2022 | $1,238,000 | +211.8% | 55,858 | +309.0% | 0.00% | +100.0% |
| Q1 2022 | $397,000 | +7.6% | 13,658 | +21.8% | 0.00% | – |
| Q4 2021 | $369,000 | -60.2% | 11,215 | -44.2% | 0.00% | -100.0% |
| Q3 2021 | $927,000 | -80.8% | 20,097 | -77.0% | 0.00% | -85.7% |
| Q2 2021 | $4,820,000 | +351.3% | 87,450 | +190.5% | 0.01% | +250.0% |
| Q1 2020 | $1,068,000 | -27.1% | 30,108 | -2.0% | 0.00% | 0.0% |
| Q4 2019 | $1,466,000 | +629.4% | 30,708 | +1076.6% | 0.00% | – |
| Q3 2018 | $201,000 | -4.7% | 2,610 | +4.0% | 0.00% | – |
| Q2 2018 | $211,000 | – | 2,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |